Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy

Cardiovascular Pathology

Volumn 19, Issue 5, 2010, Pages 316-320

  Roberts, Jason D ^a   Veinot, John P ^b   Rutberg, Julie ^a   Gollob, Michael H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Cardiovascular pathology; Hypertrophic cardiomyopathy; PRKAG2 cardiac syndrome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MYOSIN HEAVY CHAIN BETA; MYOSIN HEAVY CHAIN BETA MYH7; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FIBROFATTY METAPLASIA; GENE MUTATION; GENETIC SCREENING; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; METAPLASIA; MICROSCOPY; MUSCLE HYPERTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PRKAG2 CARDIAC SYNDROME; SCINTIANGIOGRAPHY; SYNDROME X; SYSTOLIC DYSFUNCTION; WOLFF PARKINSON WHITE SYNDROME;

AMP-ACTIVATED PROTEIN KINASES; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIAC MYOSINS; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOSIN HEAVY CHAINS; PEDIGREE; SYNDROME; YOUNG ADULT;

EID: 77956445622     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2009.06.003     Document Type: Article

References (14)

1. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, and Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology Br Heart J 71 1994 215 218
2. Thiene G, Nava A, Corrado D, Rossi L, and Pennelli N Right ventricular cardiomyopathy and sudden death in young people N Engl J Med 318 1988 129 133
3. Basso C, and Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 14 2005 37 41
4. CardioGenomics home page: http://cardiogenomics.med.harvard.edu.
5. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, and Roberts R Identification of a gene responsible for familial Wolff-Parkinson-White syndrome N Engl J Med 344 2001 1823 1831
6. Awad MM, Calkins H, and Judge DP Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy Nat Clin Pract Cardiovasc Med 5 2008 258 267
7. Marian AJ, and Roberts R The molecular genetic basis for hypertrophic cardiomyopathy J Mol Cell Cardiol 33 2001 655 670
8. Garcia-Gras E, Raffaella L, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, and Marian AJ Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy J Clin Invest 109 2002 357 362
9. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, and MacDougald OA Inhibition of adipogenesis by Wnt signaling Science 289 2000 950 953
10. Masuelli L, Bei R, Sacchetti P, Scappaticci I, Francalanci P, Albonici L, Coletti A, Palumbo C, Minieri M, Fiaccavento R, Carotenuto F, Fantini C, Carosella L, Modesti A, and Di Nardo P Beta-catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts Cardiovasc Res 60 2003 376 387
11. Kemp BE, Mitchellhill KI, Stapleton D, Michell BJ, Chen ZP, and Witters LA Dealing with energy demand: The AMP-activated protein kinase Trends Biochem Sci 24 1999 22 25 (Pubitemid 29074459)
12. Banerjee SK, Ramani R, Saba S, Rager J, Tian R, Mathier MA, and Ahmad F A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia Biochem Biophys Res Commun 360 2007 381 387
13. Ferrer JC, Favre C, Gomis RR, Fernandez-Novell JM, Garcia-Rocha M, de la Iglesia N, Cid E, and Guinovart JJ Control of glycogen deposition FEBS Lett 546 2003 127 132
14. McBride A, Ghilagaber S, Nikolaev A, and Hardie DG The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor Cell Metab 9 2009 23 34